Arena Pharmaceuticals Stock Analysis
Technical stock analysis for 23 January 2019
Arena Pharmaceuticals fell by -2.68% in the last day from $44.04 to $42.86 The price has fallen in 6 of the last 10 days and is down by -0.95% for this period. Volume fell in the last day along with the stock, which is actually a good sign as volume should follow the stock. In the last day the trading volume fell by -64 624 shares and in total 422 288 shares bought and sold for approximately $18.10 million.
Close price at the end of the last trading day (Wednesday, 23rd Jan 2019) of the ARNA stock was $42.86. This is 2.68% less than the trading day before Tuesday, 22nd Jan 2019.
During day the stock fluctuated 5.18% from a day low at $42.25 to a day high of $44.44.
30 day high of the ARNA stock price was $45.11 and low was $35.04.
90 day high was $45.11 and low was $31.97.
52 week high for the Arena Pharmaceuticals - $50.05 and low - $30.00.
Arena Pharmaceuticals lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 16.74% during the next 3 months and, with 90% probability hold a price between $43.80 and $54.23 at the end of this period.
Arena Pharmaceuticals holds a sales signal from the short-term moving average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock. On further gains, the stock will meet resistance from the short-term moving average at approximately $43.14. On a fall, the stock will find some support from the long-term average at approximately $40.89. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sales signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sales signal was issued from a pivot top point on Tuesday January 22, 2019, which indicates further falls until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.
Relative Strength Index (RSI)
RSI14 is 60 and the stock is currently not being overbought or oversold
Support & Resistance
Arena Pharmaceuticals finds support from accumulated volume at $41.68.
This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $2.19 between high and low, or 5.18%. For the last week, the stock has had a daily average volatility of 3.90%.
Our recommended stoploss: $40.46 (-5.60%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from pivot top found 1 days ago.)
Very Low Low Medium High Very High
Arena Pharmaceuticals holds several positive signals, but we still don't find these to be enough for a buy-recommendation. At the current level we recommend to hold or accumulate in this position whilst awaiting for further development. Due to some small weaknesses in the technical picture we have downgraded our recommendation for this stock since last evaluation from a Strong Buy Candidate to a Hold/Accumulate.
|ARNA $42.86 $-1.18(-2.68%)|
ARNA is down $1.18 today, but where's it headed in 2019?
|Zacks Investment Research is releasing its prediction for ARNA based on the 1-3 month system that more than doubles the S&P 500.
Click here – the ARNA analysis is free »